Skip to content
Top Globe News – Lifestyle
Author:
Kailera Therapeutics, Inc.
Hengrui Pharma and Kailera Therapeutics Announce Clinical Data Presentations at the American Diabetes Association 86th Scientific Sessions
May 13, 2026
Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
April 28, 2026
Kailera Therapeutics Announces Pricing of Initial Public Offering
April 28, 2026
←
Previous Page
1
2